DK168564B1 - Anvendelse af N-acylerede derivater af L-tryptophan til fremstilling af et lægemiddel til lindring af human smerte, farmaceutiske præparater indeholdende dem, samt sådanne nye farmaceutisk aktive derivater - Google Patents

Anvendelse af N-acylerede derivater af L-tryptophan til fremstilling af et lægemiddel til lindring af human smerte, farmaceutiske præparater indeholdende dem, samt sådanne nye farmaceutisk aktive derivater Download PDF

Info

Publication number
DK168564B1
DK168564B1 DK381486A DK381486A DK168564B1 DK 168564 B1 DK168564 B1 DK 168564B1 DK 381486 A DK381486 A DK 381486A DK 381486 A DK381486 A DK 381486A DK 168564 B1 DK168564 B1 DK 168564B1
Authority
DK
Denmark
Prior art keywords
analgesic
tryptophan
compounds
derivatives
effect
Prior art date
Application number
DK381486A
Other languages
Danish (da)
English (en)
Other versions
DK381486D0 (da
DK381486A (da
Inventor
Francesco Makovec
Chiste Rolando
Angelo Luigi Rovati
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of DK381486D0 publication Critical patent/DK381486D0/da
Publication of DK381486A publication Critical patent/DK381486A/da
Application granted granted Critical
Publication of DK168564B1 publication Critical patent/DK168564B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK381486A 1984-12-12 1986-08-11 Anvendelse af N-acylerede derivater af L-tryptophan til fremstilling af et lægemiddel til lindring af human smerte, farmaceutiske præparater indeholdende dem, samt sådanne nye farmaceutisk aktive derivater DK168564B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT68241/84A IT1179866B (it) 1984-12-12 1984-12-12 Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono
IT6824184 1984-12-12
EP8500672 1985-12-05
PCT/EP1985/000672 WO1986003489A1 (en) 1984-12-12 1985-12-05 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
DK381486D0 DK381486D0 (da) 1986-08-11
DK381486A DK381486A (da) 1986-08-11
DK168564B1 true DK168564B1 (da) 1994-04-25

Family

ID=11308641

Family Applications (1)

Application Number Title Priority Date Filing Date
DK381486A DK168564B1 (da) 1984-12-12 1986-08-11 Anvendelse af N-acylerede derivater af L-tryptophan til fremstilling af et lægemiddel til lindring af human smerte, farmaceutiske præparater indeholdende dem, samt sådanne nye farmaceutisk aktive derivater

Country Status (14)

Country Link
US (1) US4870097A (it)
EP (1) EP0237522B1 (it)
JP (1) JPS62501292A (it)
AT (1) ATE85976T1 (it)
AU (1) AU589938B2 (it)
CA (1) CA1256441A (it)
DE (1) DE3587122T2 (it)
DK (1) DK168564B1 (it)
ES (1) ES8706630A1 (it)
IE (1) IE58502B1 (it)
IT (1) IT1179866B (it)
PT (1) PT81674B (it)
WO (1) WO1986003489A1 (it)
ZA (1) ZA859526B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
US5089638A (en) * 1986-06-16 1992-02-18 Merck & Co., Inc. Amino acid analogs as CCK-antagonists
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
US5360814A (en) * 1991-02-28 1994-11-01 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
DE69201141T2 (de) * 1991-02-28 1995-05-11 Merrell Dow Pharma NMDA-Antagonisten.
US5484814A (en) * 1991-02-28 1996-01-16 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US20030199523A1 (en) * 2002-02-28 2003-10-23 Snutch Terrance P. Heterocyclic calcium in channel blockers
EP2311479B1 (en) 2002-09-20 2014-07-23 The Trustees of The University of Pennsylvania Compstatin analogs with improved activity
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
PL1951279T3 (pl) 2005-10-08 2017-12-29 Apellis Pharmaceuticals, Inc. Kompstatyna i jej analogi w zaburzeniach oczu
RU2474586C2 (ru) 2005-11-28 2013-02-10 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Эффективные аналоги компстатина
PL2148691T3 (pl) 2007-02-05 2015-12-31 Apellis Pharmaceuticals Inc Analogi kompstatyny do stosowania w leczeniu stanów zapalnych układu oddechowego
HUE035378T2 (en) 2009-05-01 2018-05-02 Univ Pennsylvania Compstatin with peptide framework and C-terminal modifications
US20140113874A1 (en) 2010-09-23 2014-04-24 The Trustees Of The University Of Pennsylvania Modified Compstatin With Improved Stability And Binding Properties
WO2012103377A1 (en) 2011-01-26 2012-08-02 Nico Worldwide, Inc. Remedy for migraine headache
RU2653439C9 (ru) 2011-05-11 2018-10-16 Апеллис Фармасьютикалс, Инк. Клеточно-реактивные аналоги компстатина, аналоги компстатина длительного действия или аналоги компстатина нацеленного действия и их применение
AU2012272706B2 (en) 2011-06-22 2017-07-06 Apellis Pharmaceuticals, Inc. Methods of treating chronic disorders with complement inhibitors
DK2753636T3 (da) 2011-09-07 2020-02-03 Univ Pennsylvania Compstatinanaloger med forbedret farmakokinetiske egenskaber
EP3660033B9 (en) 2012-11-15 2022-06-22 Apellis Pharmaceuticals, Inc. Long-acting compstatin analogs and related compositions and methods
WO2014152391A1 (en) 2013-03-15 2014-09-25 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
US10213476B2 (en) 2014-03-17 2019-02-26 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
EP3359555B1 (en) 2015-10-07 2023-12-20 Apellis Pharmaceuticals, Inc. Dosing regimens
EP3374027B1 (en) * 2015-11-12 2021-06-23 The Trustees of Columbia University in the City of New York Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics
CA3059304A1 (en) 2017-04-07 2018-10-11 Apellis Pharmaceuticals, Inc. Dosing regimens and related compositions and methods
EP3615053A4 (en) 2017-04-25 2021-07-14 Temple Otorongo LLC PHARMACEUTICAL COMPOSITION CONSISTING OF TRYPTOPHAN AND A PHYLLOKININ DERIVATIVE FOR USE IN THE TREATMENT OF PSYCHIATRIC AND PSYCHOLOGICAL DISORDERS
HUE057693T2 (hu) 2018-04-06 2022-05-28 Univ Pennsylvania Fokozott oldhatóságú és javított farmakokinetikai tulajdonságú kompsztatin analógok

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055518B (it) * 1971-05-18 1982-01-11 Rotta Research Lab Derivatives del triptofano
US4482567A (en) * 1982-10-07 1984-11-13 Research Foundation For Mental Hygiene, Inc. N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics

Also Published As

Publication number Publication date
PT81674B (pt) 1987-10-20
ES8706630A1 (es) 1987-06-01
IT8468241A0 (it) 1984-12-12
DK381486D0 (da) 1986-08-11
JPS62501292A (ja) 1987-05-21
IE853029L (en) 1986-06-12
AU589938B2 (en) 1989-10-26
IE58502B1 (en) 1993-10-06
PT81674A (en) 1986-01-01
ATE85976T1 (de) 1993-03-15
ES549822A0 (es) 1987-06-01
CA1256441A (en) 1989-06-27
DE3587122D1 (de) 1993-04-01
IT1179866B (it) 1987-09-16
IT8468241A1 (it) 1986-06-12
AU5209986A (en) 1986-07-01
WO1986003489A1 (en) 1986-06-19
ZA859526B (en) 1986-08-27
EP0237522A1 (en) 1987-09-23
DK381486A (da) 1986-08-11
US4870097A (en) 1989-09-26
EP0237522B1 (en) 1993-02-24
DE3587122T2 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
DK168564B1 (da) Anvendelse af N-acylerede derivater af L-tryptophan til fremstilling af et lægemiddel til lindring af human smerte, farmaceutiske præparater indeholdende dem, samt sådanne nye farmaceutisk aktive derivater
KR101783633B1 (ko) 섬유근육통 증후군의 치료 방법
AU2008241012B2 (en) Tapentadol for treating pain from arthritis
Shankariah et al. Tramadol versus ketorolac in the treatment of postoperative pain following maxillofacial surgery
EA000976B1 (ru) Композиция для снятия боли и способ снятия боли
CN102014908A (zh) 具有组合的sert、5-ht3和5-ht1a活性的化合物的治疗用途
JP2021526507A (ja) 発作により誘発される突然死を処置するための組成物および方法
JP2010521516A (ja) 疼痛および過敏性腸症候群の治療におけるキノリン誘導体の使用
BRPI0614701A2 (pt) usos de um composto para melhorar a vigìlia e composições farmacêuticas
JP2012502915A (ja) てんかんを治療する組成物及び方法
JPS59501460A (ja) カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法
RU2126254C1 (ru) Применение бисфенилалкилпиперазинов для лечения расстройств, вызванных злоупотреблением веществами, и способ лечения
Tonini et al. 5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract
US6638928B1 (en) Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
EP2475361B1 (en) N-substituted benzenepropanamides for use in the treatment of pain and inflammation
KR20100092956A (ko) 세로토닌 수송체, 세로토닌 수용체 및 노드아드레날린 수송체에 친화성을 갖는 화합물의 치료 용도
JP5600253B2 (ja) 情動障害の治療のための［２−（６−フルオロ−１ｈ−インドール−３−イルスルファニル）ベンジル］メチルアミン
TWI233802B (en) The use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
EA017432B1 (ru) 4-[2,3-дифтор-6-(2-фтор-4-метилфенилсульфанил)фенил]пиперидин
SK12132001A3 (sk) Terapeutická látka s obsahom piperidínového derivátu a jej použitie
EA016869B1 (ru) КОМБИНАЦИЯ ПРОИЗВОДНЫХ ТРИАЗИНА И АГОНИСТОВ PPARα
Poitras New Therapeutic Approaches to Upper Gastrointestinal Motility Disorders
Sorbera et al. Z-338
WO2009112541A2 (en) [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
TW201103546A (en) New use of 5H-dibenz/b,f/azepine-5-carboxamide derivatives

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed